+

Cookies on the Business Insider India website

Business Insider India has updated its Privacy and Cookie policy. We use cookies to ensure that we give you the better experience on our website. If you continue without changing your settings, we\'ll assume that you are happy to receive all cookies on the Business Insider India website. However, you can change your cookie setting at any time by clicking on our Cookie Policy at any time. You can also see our Privacy Policy.

Close
HomeQuizzoneWhatsappShare Flash Reads
 

Read the FDA report on the death of a woman who was taking a new Alzheimer's drug, reigniting safety concerns

Dec 13, 2021, 20:09 IST
Business Insider
A Biogen employee works in the company's lab.Suzanne Kreiter/The Boston Globe via Getty Images

Hello,

Advertisement

Welcome to Insider Healthcare. I'm healthcare editor Leah Rosenbaum, and today in healthcare news:

If you're new to this newsletter, sign up here. Comments, tips? Email me at lrosenbaum@insider.com or tweet @leah_rosenbaum. Let's get to it...

A woman died while taking a controversial new Alzheimer's drug, increasing concerns about its safety. Read the FDA report on what happened.

See the document>>

A passenger who arrived from Italy administers a self-collected nasal swab.Mario Tama/Getty Images
The most common Omicron symptoms include cough, fatigue, and a runny nose, according to health officials in the US and Europe

Read more>>

Advertisement

Dr. Richard Schwartz celebrates after receiving his COVID-19 Pfizer vaccine booster on October 6, 2021.Lev Radin/Pacific Press/LightRocket via Getty Images

Here's the data we have so far on the Omicron variant versus our vaccines — what scientists have found, and what remains unanswered

Here's what we know>>

More stories we're reading:

-Leah

You are subscribed to notifications!
Looks like you've blocked notifications!
Next Article